Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 13
2010 8
2011 11
2012 5
2013 4
2014 9
2015 6
2016 8
2017 8
2018 9
2019 11
2020 10
2021 2
2022 8
2023 7
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
The Landscape of Targeted Therapies in TNBC.
Vagia E, Mahalingam D, Cristofanilli M. Vagia E, et al. Among authors: mahalingam d. Cancers (Basel). 2020 Apr 8;12(4):916. doi: 10.3390/cancers12040916. Cancers (Basel). 2020. PMID: 32276534 Free PMC article. Review.
Targeting HSP90 for cancer therapy.
Mahalingam D, Swords R, Carew JS, Nawrocki ST, Bhalla K, Giles FJ. Mahalingam D, et al. Br J Cancer. 2009 May 19;100(10):1523-9. doi: 10.1038/sj.bjc.6605066. Epub 2009 Apr 28. Br J Cancer. 2009. PMID: 19401686 Free PMC article. Review.
Review: Oncolytic virotherapy, updates and future directions.
Fountzilas C, Patel S, Mahalingam D. Fountzilas C, et al. Among authors: mahalingam d. Oncotarget. 2017 May 31;8(60):102617-102639. doi: 10.18632/oncotarget.18309. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254276 Free PMC article. Review.
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.
Carneiro BA, Cavalcante L, Mahalingam D, Saeed A, Safran H, Ma WW, Coveler AL, Powell S, Bastos B, Davis E, Sahai V, Mikrut W, Longstreth J, Smith S, Weisskittel T, Li H, Borden BA, Harvey RD, Sahebjam S, Cervantes A, Koukol A, Mazar AP, Steeghs N, Kurzrock R, Giles FJ, Munster P. Carneiro BA, et al. Among authors: mahalingam d. Clin Cancer Res. 2024 Feb 1;30(3):522-531. doi: 10.1158/1078-0432.CCR-23-1916. Clin Cancer Res. 2024. PMID: 37982822 Clinical Trial.
Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network.
Judge SJ, Ghalambor T, Cavnar MJ, Lidsky ME, Merkow RP, Cho M, Dominguez-Rosado I, Karanicolas PJ, Mayo SC, Rocha FG, Fields RC, Patel RA, Kennecke HF, Koerkamp BG, Yopp AC, Petrowsky H, Mahalingam D, Kemeny N, D'Angelica M, Gholami S. Judge SJ, et al. Among authors: mahalingam d. Ann Surg Oncol. 2023 Nov;30(12):7362-7370. doi: 10.1245/s10434-023-14207-7. Epub 2023 Sep 13. Ann Surg Oncol. 2023. PMID: 37702903 Free PMC article.
Immunotherapy in colorectal cancer: for the select few or all?
Arora SP, Mahalingam D. Arora SP, et al. Among authors: mahalingam d. J Gastrointest Oncol. 2018 Feb;9(1):170-179. doi: 10.21037/jgo.2017.06.10. J Gastrointest Oncol. 2018. PMID: 29564183 Free PMC article. Review.
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).
Maldonado E, Rathmell WK, Shapiro GI, Takebe N, Rodon J, Mahalingam D, Trikalinos NA, Kalebasty AR, Parikh M, Boerner SA, Balido C, Krings G, Burns TF, Bergsland EK, Munster PN, Ashworth A, LoRusso P, Aggarwal RR. Maldonado E, et al. Among authors: mahalingam d. Cancer Res Commun. 2024 Jul 1;4(7):1793-1801. doi: 10.1158/2767-9764.CRC-24-0213. Cancer Res Commun. 2024. PMID: 38920407 Free PMC article. Clinical Trial.
The Pim kinases: new targets for drug development.
Swords R, Kelly K, Carew J, Nawrocki S, Mahalingam D, Sarantopoulos J, Bearss D, Giles F. Swords R, et al. Among authors: mahalingam d. Curr Drug Targets. 2011 Dec;12(14):2059-66. doi: 10.2174/138945011798829447. Curr Drug Targets. 2011. PMID: 21777193 Review.
116 results